Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety

September 14, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA Statement on agency’s commitment to studying breast implant safety
Short Title: FDA Statement on agency’s commitment to studying breast implant safety

Post navigation

← BioLyte Laboratories Issues Voluntary Nationwide Recall Due to the Voluntary Nationwide Recall initiated by King Bio Inc. (a Raw Material Supplier) for NeoRelief for Muscle Cramping and Restlessness Topical Gel Due to Possible Microbial Contamination FDA approves device for treatment of acute coronary artery perforations →
Proudly powered by WordPress